Is cyclooxygenase-2 important in skin carcinogenesis?

Area of Science:

• Biochemistry
• Molecular Biology
• Dermatology

Background:

• Arachidonic acid metabolites, particularly prostaglandins (PGs), are implicated in skin carcinogenesis.
• Cyclooxygenase-2 (COX-2) expression is elevated in skin tumors, suggesting its critical role in cancer development.
• Understanding the regulation of COX-2 and the role of PGs is crucial for developing chemopreventive strategies.

Purpose of the Study:

• To investigate the role of prostaglandins (PGs) and cyclooxygenase (COX) isoforms in chemical and UV-induced skin carcinogenesis.
• To identify regulatory elements and transcription factors involved in COX-2 gene expression.
• To evaluate the efficacy of nonsteroidal anti-inflammatory drugs (NSAIDs) in preventing and treating skin cancer.

Main Methods:

• Murine models of chemically and UV-induced skin carcinogenesis were utilized.
• COX-2 promoter activity was analyzed using luciferase reporter vectors.
• NSAIDs, including selective COX-2 inhibitors, were administered orally and topically to assess their effects on tumor development and regression.

Main Results:

• COX-2 expression was constitutively upregulated in skin tumors, while COX-1 showed minimal change.
• Specific regulatory regions (E box, NF-IL6 site) and transcription factors (C/EBP family) were identified for COX-2 expression.
• Oral or topical administration of NSAIDs, including celecoxib, significantly inhibited UV-induced skin cancer development (up to 85%) and caused regression of existing tumors.

Conclusions:

• Prostaglandin synthesis plays a critical role in skin cancer development.
• COX-2 is a key mediator in skin carcinogenesis, and its inhibition holds therapeutic potential.
• NSAIDs, particularly selective COX-2 inhibitors, demonstrate significant chemopreventive and therapeutic efficacy against skin cancer.